Development of a multiplex autoantibody test for detection of lung cancer

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Jia, Jing ^a   Wang, Wenzhe ^a   Meng, Wen ^b   Ding, Mingjian ^a   Ma, Shenglin ^a,b   Wang, Xiaoju ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; HYBRID PROTEIN; LIGAND; MICROSPHERE;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD ANALYSIS; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; EARLY DIAGNOSIS; FEMALE; HIGH RISK PATIENT; HIGH RISK POPULATION; HIGH THROUGHPUT SCREENING; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IN VITRO STUDY; LUNG CANCER; MALE; PROTEIN PURIFICATION; SURVIVAL RATE; TUMOR CELL; BIOLOGICAL MODEL; BLOOD; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; LUNG NEOPLASMS; MIDDLE AGED; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY;

ADULT; AGED; AUTOANTIBODIES; CASE-CONTROL STUDIES; CROSS REACTIONS; EARLY DETECTION OF CANCER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIGANDS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 84899699128     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095444     Document Type: Article

References (37)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
2. Bradley CJ, Given CW, Roberts C (2001) Disparities in cancer diagnosis and survival. Cancer 91: 178-188. (Pubitemid 32052629)
3. Baykul T, Yilmaz HH, Aydin U, Aydin MA, Aksoy M, et al. (2010) Early diagnosis of oral cancer. J Int Med Res 38: 737-749.
4. Kaur S, Baine MJ, Jain M, Sasson AR, Batra SK (2012) Early diagnosis of pancreatic cancer: challenges and new developments. Biomark Med 6: 597-612.
5. Jemal A, Clegg LX, Ward E, Ries LA, Wu X, et al. (2004) Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 101: 3-27. (Pubitemid 38812419)
6. Brower V (2009) Biomarker studies abound for early detection of lung cancer. J Natl Cancer Inst 101: 11-13.
7. Zhong L, Coe SP, Stromberg AJ, Khattar NH, Jett JR, et al. (2006) Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol 1: 513-519. (Pubitemid 47181397)
8. de Visser KE, Eichten A, Coussens LM (2006) Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6: 24-37. (Pubitemid 43053650)
9. Tan EM (2001) Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J Clin Invest 108: 1411-1415.
10. Yao X, Jiang H, Zhang C, Wang H, Yang L, et al. (2010) Dickkopf-1 autoantibody is a novel serological biomarker for non-small cell lung cancer. Biomarkers 15: 128-134.
11. Zhang Y, Ying X, Han S, Wang J, Zhou X, et al. (2013) Autoantibodies against insulin-like growth factorbinding protein-2 as a serological biomarker in the diagnosis of lung cancer. Int J Oncol 42: 93-100.
12. Pereira-Faca SR, Kuick R, Puravs E, Zhang Q, Krasnoselsky AL, et al. (2007) Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer. Cancer Res 67: 12000-12006.
13. de Visser KE, Korets LV, Coussens LM (2005) De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7: 411-423. (Pubitemid 40719125)
14. Nesterova M, Johnson N, Cheadle C, Cho-Chung YS (2006) Autoantibody biomarker opens a new gateway for cancer diagnosis. Biochim Biophys Acta 1762: 398-403. (Pubitemid 43344300)
15. Chen JS, Kuo YB, Chou YP, Chan CC, Fan CW, et al. (2011) Detection of autoantibodies against Rabphilin-3A-like protein as a potential biomarker in patient's sera of colorectal cancer. Clin Chim Acta 412: 1417-1422.
16. Casiano CA, Mediavilla-Varela M, Tan EM (2006) Tumor-associated antigen arrays for the serological diagnosis of cancer. Mol Cell Proteomics 5: 1745-1759. (Pubitemid 44688185)
17. Farlow EC, Patel K, Basu S, Lee BS, Kim AW, et al. (2010) Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer. Clin Cancer Res 16: 3452-3462.
18. Elshal MF, McCoy JP (2006) Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 38: 317-323.
19. Fu Q, Zhu J, Van Eyk JE (2010) Comparison of multiplex immunoassay platforms. Clin Chem 56: 314-318.
20. Pickering JW, Martins TB, Greer RW, Schroder MC, Astill ME, et al. (2002) A multiplexed fluorescent microsphere immunoassay for antibodies to pneumococcal capsular polysaccharides. Am J Clin Pathol 117: 589-596. (Pubitemid 34823689)
21. Los GV, Encell LP, McDougall MG, Hartzell DD, Karassina N, et al. (2008) HaloTag: a novel protein labeling technology for cell imaging and protein analysis. ACS Chem Biol 3: 373-382.
22. Kovalenko EI, Ranjbar S, Jasenosky LD, Goldfeld AE, Vorobjev IA, et al. (2011) The use of HaloTag-based technology in flow and laser scanning cytometry analysis of live and fixed cells. BMC Res Notes 4: 340.
23. Yao Y, Fan Y, Wu J, Wan H, Wang J, et al. (2012) Potential application of nonsmall cell lung cancer-associated autoantibodies to early cancer diagnosis. Biochem Biophys Res Commun 423: 613-619.
24. Mack U, Ukena D, Montenarh M, Sybrecht GW (2000) Serum anti-p53 antibodies in patients with lung cancer. Oncol Rep 7: 669-674.
25. Sangrajrang S, Sornprom A, Chernrungroj G, Soussi T (2003) Serum p53 antibodies in patients with lung cancer: correlation with clinicopathologic features and smoking. Lung Cancer 39: 297-301. (Pubitemid 36284730)
26. Chen G, Wang X, Yu J, Varambally S, Thomas DG, et al. (2007) Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma. Cancer Res 67: 3461-3467. (Pubitemid 46724887)
27. Yagihashi A, Asanuma K, Kobayashi D, Tsuji N, Shijubo Y, et al. (2005) Detection of autoantibodies to livin and survivin in Sera from lung cancer patients. Lung Cancer 48: 217-221.
28. Chang JW, Lee SH, Jeong JY, Chae HZ, Kim YC, et al. (2005) Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer. FEBS Lett 579: 2873-2877.
29. Tureci O, Mack U, Luxemburger U, Heinen H, Krummenauer F, et al. (2006) Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1. Cancer Lett 236: 64-71.
30. Ma L, Yue W, Zhang L, Wang Y, Zhang C, et al. (2010) [Clinical significance and diagnostic value of Survivin autoantibody in non-small cell lung cancer patients]. Zhongguo Fei Ai Za Zhi 13: 706-712.
31. Liu W, Peng B, Lu Y, Xu W, Qian W, et al. (2011) Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis. Autoimmun Rev 10: 331-335.
32. Chapman CJ, Murray A, McElveen JE, Sahin U, Luxemburger U, et al. (2008) Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax 63: 228-233. (Pubitemid 351373718)
33. Rom WN, Goldberg JD, Addrizzo-Harris D, Watson HN, Khilkin M, et al. (2010) Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers. BMC Cancer 10: 234.
34. Qiu J, Choi G, Li L, Wang H, Pitteri SJ, et al. (2008) Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera. J Clin Oncol 26: 5060-5066.
35. Ostroff RM, Bigbee WL, Franklin W, Gold L, Mehan M, et al. (2010) Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer. PLoS One 5: e15003.
36. Boyle P, Chapman CJ, Holdenrieder S, Murray A, Robertson C, et al. (2011) Clinical validation of an autoantibody test for lung cancer. Ann Oncol 22: 383- 389.
37. Leidinger P, Keller A, Heisel S, Ludwig N, Rheinheimer S, et al. (2010) Identification of lung cancer with high sensitivity and specificity by blood testing. Respir Res 11: 18.